Cambricon Technologies (688256) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Mar, 2026Executive summary
Achieved first full-year profitability, with net profit attributable to shareholders of RMB 2.06 billion, reversing prior losses year-over-year.
Annual revenue reached RMB 6.50 billion, up 453.21% compared to the previous year, driven by surging AI computing demand.
Gross profit totaled RMB 3.58 billion, up 437.99% year-over-year.
Major business lines include cloud AI chips, edge AI chips, IP licensing, and intelligent computing clusters.
Financial highlights
Revenue: RMB 6.50 billion, up 453.21% year-over-year.
Net profit attributable to shareholders: RMB 2.06 billion, compared to a net loss of RMB 452 million last year.
Net profit excluding non-recurring items: RMB 1.77 billion.
Basic EPS: RMB 4.93; diluted EPS: RMB 4.88.
Gross margin: 55.15%, down 1.56 percentage points year-over-year.
Operating cash flow: -RMB 498 million, improved from -RMB 1.62 billion last year.
R&D investment: RMB 1.17 billion, up 9.03% year-over-year, accounting for 17.99% of revenue.
Net assets: RMB 11.84 billion, up 118.27% from last year.
Total assets: RMB 13.44 billion, up 100.03% year-over-year.
Outlook and guidance
Will focus on expanding AI chip product lines for large models and vertical industries.
Plans to deepen industry customer engagement and accelerate product iteration.
Intends to strengthen ecosystem partnerships and talent development.
Expects continued high R&D investment to maintain technology leadership.
Latest events from Cambricon Technologies
- Revenue up 65.56% and net loss narrowed 47.76% year-over-year, driven by AI market growth.688256
Q4 202416 Dec 2025 - Revenue up 4,347.82% to RMB 2.88B, net profit RMB 1.04B, strong AI chip growth.688256
Q2 202512 Dec 2025 - Net profit of ¥1.60 billion and 2,386% revenue growth mark a dramatic turnaround.688256
Q3 202518 Oct 2025 - Q3 revenue soared, but losses and cash outflows continued amid heavy R&D investment.688256
Q3 202413 Jun 2025 - Revenue dropped 43% but net loss narrowed as R&D intensity and gross margin remained high.688256
H1 202413 Jun 2025 - Revenue and net profit surged, but cash flow and supply chain risks remain.688256
Q1 20256 Jun 2025